Company:  BIOCARDIA, INC. (BCDA)
Form Type:  10-Q
Filing Date:  5/15/2019 
CIK:  0000925741 
Address:  125 SHOREWAY ROAD
SUITE B
 
City, State, Zip:  SAN CARLOS, California 94070 
Telephone:  650-226-0123 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.63  
Change: 
0.38 (4.61%)  
Trade Time: 
Jul 19  
Market Cap: 
$41.83M
Trade BCDA now with 

© 2019  
Description of Business
We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. Our lead therapeutic candidate is the investigational CardiAMP Cell Therapy System, which provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications: heart failure that develops after a heart attack and chronic myocardial ischemia. Chronic myocardial ischemia involves sustained poor blood perfusion to the heart muscle often at the microvascular level.
Register and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II. OTHER INFORMATION
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      ITEM 3. DEFAULTS UPON SENIOR SECURITIES
      ITEM 4. MINE SAFETY DISCLOSURES
      ITEM 5. OTHER INFORMATION
      ITEM 6. EXHIBIT INDEX
    SIGNATURES
  EXHIBIT 31.1
    Certification of Principal Executive Officer
  EXHIBIT 31.2
    Certification of Principal Financial Officer
  EXHIBIT 32.1
    Certification of Principal Executive Officer
  EXHIBIT 32.2
    Certification of Principal Financial Officer